CD8A and neoplasm: IL-10 is usually regarded as an anti-inflammatory cytokine and has been reported to exert anti-tumor effects through the increasing tumor antigen-specific CD8+ T cell infiltration and the INF-γ-mediated induction of antigen presentation [12,25,26,27].